1. Home
  2. TWST vs CLM Comparison

TWST vs CLM Comparison

Compare TWST & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • CLM
  • Stock Information
  • Founded
  • TWST 2013
  • CLM 1987
  • Country
  • TWST United States
  • CLM United States
  • Employees
  • TWST N/A
  • CLM N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • CLM Finance/Investors Services
  • Sector
  • TWST Health Care
  • CLM Finance
  • Exchange
  • TWST Nasdaq
  • CLM Nasdaq
  • Market Cap
  • TWST 1.8B
  • CLM 1.9B
  • IPO Year
  • TWST 2018
  • CLM N/A
  • Fundamental
  • Price
  • TWST $34.64
  • CLM $7.79
  • Analyst Decision
  • TWST Buy
  • CLM
  • Analyst Count
  • TWST 10
  • CLM 0
  • Target Price
  • TWST $49.10
  • CLM N/A
  • AVG Volume (30 Days)
  • TWST 1.1M
  • CLM 1.4M
  • Earning Date
  • TWST 08-01-2025
  • CLM 01-01-0001
  • Dividend Yield
  • TWST N/A
  • CLM 18.74%
  • EPS Growth
  • TWST N/A
  • CLM N/A
  • EPS
  • TWST N/A
  • CLM N/A
  • Revenue
  • TWST $347,680,000.00
  • CLM N/A
  • Revenue This Year
  • TWST $22.58
  • CLM N/A
  • Revenue Next Year
  • TWST $17.71
  • CLM N/A
  • P/E Ratio
  • TWST N/A
  • CLM N/A
  • Revenue Growth
  • TWST 25.30
  • CLM N/A
  • 52 Week Low
  • TWST $27.12
  • CLM $6.25
  • 52 Week High
  • TWST $60.90
  • CLM $8.84
  • Technical
  • Relative Strength Index (RSI)
  • TWST 55.33
  • CLM 56.25
  • Support Level
  • TWST $33.41
  • CLM $7.77
  • Resistance Level
  • TWST $36.39
  • CLM $8.08
  • Average True Range (ATR)
  • TWST 1.97
  • CLM 0.08
  • MACD
  • TWST 0.62
  • CLM -0.03
  • Stochastic Oscillator
  • TWST 75.28
  • CLM 21.62

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About CLM Cornerstone Strategic Value Fund Inc. New

Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.

Share on Social Networks: